First National Corporation Redeems Preferred Stock

New Post Public Reply Private Reply Replies (0) Message Board
News Desk 2018
First National Corporation Redeems Preferred Stock

STRASBURG, Va., Nov. 09, 2015 (GLOBE NEWSWIRE) -- First National Corporation (the “Company”) (OTC:FXNC), the parent company of First Bank (the “Bank”), today announced its redemption of all 13,900 shares of Series A preferred stock at par for $13.9 million and all 695 shares of Series B preferred stock at par for $695 thousand on November 6, 2015.  The Company also paid accrued dividends through November 5, 2015, totaling $20.30 per share on both the Series A and Series B preferred stock.   The Company was able to complete the previously-announced redemption on November 6, 2015 instead of the originally planned date of December 2, 2015.

About the Company

First National Corporation, headquartered in Strasburg, Virginia, is the bank holding company of First Bank, a community bank that first opened for business in 1907.  The Bank offers loan, deposit, and wealth management products and services from 17 office locations located throughout the Shenandoah Valley and central regions of Virginia. Banking services are also accessed from the Bank’s website, www.fbvirginia.com , and from a network of ATMs located throughout its market areas.  The Bank operates a wealth management division under the name First Bank Wealth Management as well as a mortgage division.  First Bank also owns First Bank Financial Services, Inc., which invests in entities that provide investment services and title insurance.

Caution about Forward Looking Statements

Certain information contained in this discussion may include “forward-looking statements” within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements relate to the Company’s future operations and are generally identified by phrases such as “the Company expects,” “the Company believes” or words of similar import. Although the Company believes that its expectations with respect to the forward-looking statements are based upon reliable assumptions within the bounds of its knowledge of its business and operations, there can be no assurance that actual results, performance or achievements of the Company will not differ materially from any future results, performance or achievements expressed or implied by such forward-looking statements. For details on factors that could affect expectations, see the risk factors and other cautionary language included in the Company’s Annual Report on Form 10-K for the year ended December 31, 2014, and other filings with the Securities and Exchange Commission.

 

Contacts: Scott C. Harvard                                                                                                                                                                                              President and CEO                                                                                                                                                                                         (540) 465-9121                                                                                                                                                                                                sharvard@fbvirginia.com                                                                                                                                                                              M. Shane Bell Executive Vice President and CFO (540) 465-9121                                                                                                                                                                                                sbell@fbvirginia.com

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Duolingo Faces Lawsuit Over Alleged Investor Missteps

Updated Category News Views 8

Fasten your seatbelts, folks. We're diving into a legal tussle that could shake things up for Duolingo, Inc. (NASDAQ: DUOL). Investors who plunged into Duolingo shares between May 2, 2025, and February 26, 2026, might be feeling the heat now. They ought to brace for a class-action lawsuit frenzy with fingers pointed at Duolingo for allegedly pulling wool over investors'...

Continue Reading
2026 Community Impact Week: Slam Dunk for Community Unity

Updated Category News Views 4

Alright, if you're looking for a story that gives you those warm fuzzy feelings while wrapping you in a big sports hug, here it is. Imagine this: you've got basketball legends, world-class athletes, and a corporate heavyweight, all huddling up to make a community impact that's more than just warm air. Hoops, Hope, and High Fives The NBA Cares x Sands Cares Community...

Continue Reading
Phase I of 2026 Hong Kong Trade Shows Highlights Innovation

Updated Category News Views 7

Hong Kong Takes Center Stage in Global Commerce Flip through the economic landscape today, and you’ll spot Hong Kong, decked out in its best as a trade linchpin—with over 2,100 suppliers gathered under one roof. AsiaWorld-Expo is buzzing with the commencement of Phase I of the October 2026 Global Sources Hong Kong Shows. The theme's all about 'Connecting Global...

Continue Reading
LEGO Mashes Star Wars and Marvel for Fans' Delight

Updated Category News Views 6

A New Chapter in LEGO's Story Well, well, what do we have here? LEGO's throwing down the gauntlet. For the first time, they're asking fans to merge two colossal universes: Star Wars and Marvel. Talk about a brains-and-bricks bonanza! Announced at New York Comic Con with some star power from Kevin Smith, this LEGO Ideas challenge opens doors for fan creativity that might...

Continue Reading
AbbVie's SKYRIZI and RINVOQ Highlight IBD Control Advances

Updated Category News Views 3

A Deeper Look Into AbbVie's Latest Data Let's cut straight to the science, folks. At the recent American College of Gastroenterology 2026 Annual Scientific Meeting, AbbVie pulled the curtain on 22 fresh scientific abstracts that are really shaking things up in the field of inflammatory bowel disease (IBD) treatment. Data from the Phase 3 AFFIRM study shined especially...

Continue Reading
Pacira BioSciences Faces Shareholder Revolt in M&A Deal

Updated Category News Views 3

A New Storm Brews Over Pacira's Sale to Viatris They say where there's smoke, there's fire, and it looks like Pacira BioSciences, Inc. (NASDAQ: PCRX) is running right into a bonfire thanks to their upcoming sale to Viatris Inc. On the face of it, shareholders are looking at a tidy $36.50 in cash per share, but not everyone's buying the deal as fair. Enter lawman Juan...

Continue Reading
Southern Company Sparks Swift Power Restoration Post-Isaias

Updated Category News Views 10

Well, when Mother Nature decides to throw a tantrum, it takes seasoned hands and savvy tech to clean up the mess. That's exactly what Southern Company is doing after Hurricane Isaias wreaked havoc on the Southeast. With their electric utilities—Alabama Power, Georgia Power, and Mississippi Power—hitting the ground running, they've already restored power to a whopping...

Continue Reading
AI Drives Major Time Savings in Endoscopy Tech

Updated Category News Views 9

AI in Endoscopy: Game-Changer or Gimmick? Stumbling across AnX Robotica's latest pitch about their NaviCam ProScan AI workflow, one can't help but feel a mix of curiosity and skepticism. With the stakes in medical tech sky-high, they've fired off some impressive stats that grab attention. We're talking about cutting small-bowel capsule review times by a whopping...

Continue Reading
Sebela Pharma's Tegoprazan Posts Strong Phase 3 Data

Updated Category News Views 6

Spotlight on Tegoprazan: A New Player on the GERD Field Sometimes, a pharma company turns heads with data that speaks for itself. This time, Sebela Pharmaceuticals is doing just that with Tegoprazan's phase 3 results, shining a light on an area overlooked for too long: non-erosive reflux disease (NERD). Showing promise in its latest trials, Tegoprazan is muscling into the...

Continue Reading
Celltrion Unveils New Data on Infliximab: ACG 2026 Insight

Updated Category News Views 3

First Impressions: Celltrion's Latest Revelation Alright, let's jump straight into it. Celltrion USA is flaunting its latest findings on ZYMFENTRA® (infliximab-dyyb) for Crohn's disease and ulcerative colitis right at the American College of Gastroenterology's (ACG) grand event in 2026. If you've been watching the healthcare sector, this is significant news. It's got all...

Continue Reading

Top 5 Most Recently Viewed Articles

Deadline Looms for Insulet Lawsuit Investors

Updated Category News Views 25

Tick Tock: Investors, Your Clock's Running Out We're not talking about your everyday hiccup here. Insulet Corporation (NASDAQ: PODD) investors have some major decisions to make fast. If there's one deadline you can't afford to sleep through, it's the one coming up on August 31, 2026. That's when folks who've taken a hit investing in Insulet are up to their necks in legal...

Continue Reading
Essential Strategies for Staying Cool This Summer on a Budget

Updated Category News Views 149

Essential Strategies for Staying Cool This Summer on a Budget C & C Heating & Air Conditioning emphasizes a comprehensive approach to reducing energy consumption and maintaining sustainability. C & C Heating & Air Conditioning, a renowned heating and cooling service provider with over seventy years of industry experience, suggests that homeowners can enjoy a cooler...

Continue Reading
F.N.B. Corporation Announces Quarterly Dividend of $0.12

Updated Category News Views 151

F.N.B. Corporation Dividend Announcement F.N.B. Corporation (NYSE: FNB) has officially announced the declaration of a quarterly cash dividend, set at $0.12 per share for its common stock. This move reflects the corporation's strong commitment to rewarding its shareholders and maintaining a solid financial foundation. Details of the Dividend Declaration The dividend is...

Continue Reading
Analyzing Visa's Competitive Edge in Financial Services

Updated Category News Views 231

Understanding Visa's Market Position In a world driven by financial innovation and fierce competition, it's essential for investors and enthusiasts to closely examine the players in the financial services sector. This article delves into Visa (NYSE: V) and contrasts its performance against that of its main competitors. By looking at crucial financial metrics, market...

Continue Reading
Ethereum's Staking Revolution: New Opportunities Await Investors

Updated Category News Views 187

Ethereum's Remarkable Growth and Staking Potential The digital currency scene is buzzing with excitement as Ethereum spot ETFs have recorded impressive weekly inflows reaching $515 million, a notable first in history. This surge in investment highlights Ethereum's growing reputation as a reliable asset favored alike by institutional and retail investors. The Impact of...

Continue Reading